Kaleido Biosciences, Inc.

KLDO · OTC
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Assets
Cash & Equivalents$38,474$46,222$71,241$76,086
Short-Term Investments$0$0$0$0
Receivables$0$0$0$5
Inventory$0$0$0$0
Other Curr. Assets$3,837$2,499$2,038$309
Total Curr. Assets$42,311$48,721$73,279$76,243
Property Plant & Equip (Net)$5,665$8,462$6,742$4,693
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,161$2,161$2,285$0
Tax Assets$180$280$0$0
Other NC Assets$2,161$4,660$0$4,389
Total NC Assets$7,826$13,122$9,027$9,082
Other Assets$0$0$0$0
Total Assets$50,137$59,344$82,306$85,325
Liabilities
Payables$5,670$5,389$2,016$3,442
Short-Term Debt$16,144$2,634$68$91
Tax Payable$0$0$0$0
Deferred Revenue$828$498$7,086$7,406
Other Curr. Liab.$7,040$8,138$1,207$7,768
Total Curr. Liab.$29,682$16,659$10,377$11,301
LT Debt$5,550$18,375$20,391$14,831
Deferred Rev, NC-$180-$280$0$0
Deferred Tax Liab, NC$180$280$0$0
Other NC Liab.$4,298$3,814$2,655$998
Total NC Liab.$9,848$22,189$23,046$15,829
Other Liabilities$0$0$0$0
Cap. Leases$0$0$68$91
Total Liabilities$39,530$38,848$33,423$27,130
Equity
Pref Stock$0$0$82,306$0
Common Stock$43$36$30$24
Retained Earnings-$364,467-$274,179-$192,559-$106,228
AOCI$0$0-$82,306-$1,221
Other Equity$375,031$294,639$241,412$164,425
Total Equity$10,607$20,496$48,883$58,195
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$50,137$59,344$82,306$85,325
Net Debt-$16,780-$25,213-$50,782-$61,164